CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Altaire Pharmaceuticals, Inc. v. Paragon BioTeck, Inc.

2:17-cv-01837

Overview

Case Number 2:17-cv-01837
Filing Date 2017-03-31
Status Litigation filed
Court District Court, E.D. New York (nyed)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 28:1331 Fed. Question
Jury Demand Plaintiff

Parties

Defendant

Paragon BioTeck, Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Assad Sawaya NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

Michael Frank Autuoro

Fish & Richardson P.C.

Tel: +1 (212) 765-5070
Fax: +1 (212) 258-2291

601 Lexington Ave, 52nd Floor, New York, NY 10022

Altaire Pharmaceuticals, Inc. Operating Company

Represented By

1 Attorneys Listed

Michael Frank Autuoro

Fish & Richardson P.C.

Tel: +1 (212) 765-5070
Fax: +1 (212) 258-2291

601 Lexington Ave, 52nd Floor, New York, NY 10022

Court & Judges

Court

District Court, E.D. New York (nyed)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Docket Entries

(2 total)
Pleading / Complaint

COMPLAINT against Paragon BioTeck, Inc. filing fee $ 400, receipt number 0207-9419289 Was the Disclosure Statement on Civil Cover Sheet completed -YES,, filed by Altaire Pharmaceuticals, Inc., Assad Sawaya. (Attachments: # 1 Civil Cover Sheet, # 2 Proposed Summons, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Exhibit D, # 7 Exhibit E, # 8 Exhibit F, # 9 Exhibit G, # 10 Exhibit H, # 11 Exhibit I, # 12 Exhibit J, # 13 Exhibit K, # 14 Exhibit L, # 15 Exhibit M, # 16 Exhibit N) (Autuoro, Michael) (Entered: 04/03/2017)

Entry #1 • 2017-04-03
1

Corporate Disclosure Statement by Altaire Pharmaceuticals, Inc. (Autuoro, Michael) (Entered: 04/03/2017)

Entry #2 • 2017-04-03
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc